Personal information

No personal information available

Activities

Employment (1)

Texas Heart Institute: Houston, TX, US

Research Scientist/Assistant Director BRC (Regenerative Medicine Research)
Employment
Source: Self-asserted source
lourdes chacon Alberty

Professional activities (2)

Sigma Xi The Scientific Research Honor Society: Research Triangle Park, NC, US

Membership
Source: Self-asserted source
lourdes chacon Alberty

American Heart Association : TX, TX, US

Membership
Source: Self-asserted source
lourdes chacon Alberty

Works (5)

Effect of intraoperative support mode on circulating inflammatory biomarkers after lung transplantation surgery

Artificial Organs
2023-04 | Journal article
Contributors: Lourdes Chacon‐Alberty; Shengbin Ye; Abdussalam Elsenousi; Emma Hills; Madelyn King; Ethan D'Silva; Andres Pena Leon; Marcelo Salan‐Gomez; Meng Li; Camila Hochman‐Mendez et al.
Source: check_circle
Crossref

Drawn‐on‐Skin Sensors from Fully Biocompatible Inks toward High‐Quality Electrophysiology

Small
2022-09 | Journal article
Contributors: Shubham Patel; Faheem Ershad; Jimmy Lee; Lourdes Chacon‐Alberty; Yifan Wang; Marco A. Morales‐Garza; Arturo Haces‐Garcia; Seonmin Jang; Lei Gonzalez; Luis Contreras et al.
Source: check_circle
Crossref

Recommendations for nomenclature and definition of cell products intended for human cardiovascular use

Cardiovascular Research
2022-08-24 | Journal article
Contributors: Doris A Taylor; Lourdes Chacon-Alberty; Luiz C Sampaio; Mariana Gonzalez del Hierro; Emerson C Perin; Fernanda C P Mesquita; Timothy D Henry; Jay H Traverse; Carl J Pepine; Joshua M Hare et al.
Source: check_circle
Crossref

Mining the Mesenchymal Stromal Cell Secretome in Patients with Chronic Left Ventricular Dysfunction

Cells
2022-06-30 | Journal article
Contributors: Jacquelynn Morrissey; Fernanda C. P. Mesquita; Lourdes Chacon-Alberty; Camila Hochman-Mendez
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials.

PloS one
2020-08-25 | Journal article
Source: Self-asserted source
lourdes chacon Alberty